Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr 7:5:43.
doi: 10.3389/fendo.2014.00043. eCollection 2014.

Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates

Affiliations
Review

Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates

Andreas Hoeflich et al. Front Endocrinol (Lausanne). .

Abstract

IGFBP-2 (1) has been described as a brain tumor oncogene (2) and is widely expressed in cancers from different origins (3-8). IGFBP-2 alone cannot cause malignant transformation, yet progression of brain tumors to higher grade (9) and also has been provided as a protective element in earlier stages of multistage colon carcinogenesis (10). Therefore, it is crucial to understand the factors that determine expression patterns of IGFBP-2 under normal and malignant conditions. The present review provides a comprehensive update of known factors that have an impact on expression of IGFBP-2.

Keywords: IGFBP-2; estradiol; peptide hormones; steroids; vertebrates.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Binkert C, Landwehr J, Mary JL, Schwander J, Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J (1989) 8:2497–502 - PMC - PubMed
    1. Zhang W, Fuller G. IGFBP2 as a brain tumor oncogene. Cancer Biol Ther (2007) 6:995–6 - PubMed
    1. Chi F, Wu R, Zeng YC, Xing R, Liu Y. Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Mol Biol Rep (2013) 40:3583–9010.1007/s11033-012-2432-z - DOI - PubMed
    1. Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer (2009) 124:2416–2910.1002/ijc.24202 - DOI - PMC - PubMed
    1. Fukushima T, Kataoka H. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. Anticancer Res (2007) 27:3685–92 - PubMed